Alamar Biosciences Completes IPO, Raises $219.9M

Alamar Biosciences, Inc. announced the completion of its initial public offering on April 20, 2026, successfully raising approximately $219.9 million in gross proceeds. The company issued a total of 12,937,500 shares of common stock, including the full exercise of the underwriters' option, at a public offering price of $17.00 per share. Concurrently with the IPO closing, the company filed an amended and restated certificate of incorporation and adopted amended and restated bylaws, which were previously approved by its board and stockholders.